Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 3.4.21.B25 - PACE4 proprotein convertase and Organism(s) Homo sapiens

for references in articles please use BRENDA:EC3.4.21.B25
preliminary BRENDA-supplied EC number
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.21 Serine endopeptidases
                3.4.21.B25 PACE4 proprotein convertase
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Homo sapiens
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Homo sapiens
The enzyme appears in selected viruses and cellular organisms
Reaction Schemes
releases mature proteins from their proproteins by cleavage of Arg-Xaa-Yaa-Arg-Zaa bonds, where Xaa can be any amino acid and Yaa is Arg or Lys
Synonyms
pace4, pace-4, proprotein convertase pace4, paired basic amino acid-cleaving enzyme 4, xpace4, pace 4, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
PACE 4
PACE-4
-
-
PACE4
paired basic amino acid cleaving enzyme 4
-
paired basic amino acid-cleaving enzyme 4
-
paired basic amino-acid-cleaving enzyme-4
-
-
S08.075
-
Merops ID
SPC4
-
-
subtilisin-like proprotein convertase
-
-
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
cleavage of C-N-linkage
hydrolysis of peptide bond
CAS REGISTRY NUMBER
COMMENTARY hide
151662-24-7
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
anthrax toxin protective antigen + H2O
?
show the reaction diagram
-
-
-
?
dipththeria toxin + H2O
?
show the reaction diagram
-
-
-
?
envelope glycoprotein gp160
?
show the reaction diagram
well activated by PaCE4
-
-
?
human immunodeficiency virus type 1 Vpr + H2O
?
show the reaction diagram
undergoes proteolytic processing at a very well conserved proprotein convertase cleavage site, R85QRR88-/-, proprotein convertases PC5 and PACE4 can efficiently process extracellular Vpr
-
-
?
insulin proreceptor + H2O
?
show the reaction diagram
-
-
-
?
insulin receptor isoform B zymogen + H2O
mature insulin receptor isoform B + ?
show the reaction diagram
L-pyroglutamyl-Arg-Thr-Lys-Arg-4-methylcoumaryl 7-amide + H2O
?
show the reaction diagram
-
-
-
?
L-pyroglutamyl-RTKR-4-methylcoumarin 7-amide + H2O
?
show the reaction diagram
-
-
-
?
low density lipoprotein receptor-elated protein + H2O
?
show the reaction diagram
-
-
-
?
pGlu-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O
?
show the reaction diagram
-
-
-
?
pGlu-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O
pGlu-Arg-Thr-Lys-Arg + 7-amino-4-methylcoumarin
show the reaction diagram
-
-
-
?
pro-beta site APP cleaving enzyme + H2O
beta site APP cleaving enzyme + ?
show the reaction diagram
-
i.e. BACE, weak substrate
-
?
pro-complement C3 + H2O
?
show the reaction diagram
-
-
-
?
pro7B2 + H2O
7B2 + ?
show the reaction diagram
-
PACE4-A
-
?
proalbumin + H2O
albumin + ?
show the reaction diagram
-
-
-
?
Pyr-Arg-Thr-Lys-Arg-4-methylcoumarin-7-amide + H2O
Pyr-Arg-Thr-Lys-Arg + 7-amino-4-methylcoumarin
show the reaction diagram
-
-
-
ir
von Willebrand factor precursor + H2O
mature von Willebrand factor + ?
show the reaction diagram
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
human immunodeficiency virus type 1 Vpr + H2O
?
show the reaction diagram
undergoes proteolytic processing at a very well conserved proprotein convertase cleavage site, R85QRR88-/-, proprotein convertases PC5 and PACE4 can efficiently process extracellular Vpr
-
-
?
insulin receptor isoform B zymogen + H2O
mature insulin receptor isoform B + ?
show the reaction diagram
maturation
-
-
?
pro-complement C3 + H2O
?
show the reaction diagram
-
-
-
?
additional information
?
-
-
enzyme binds tightly to heparin and anchors heparan sulfate proteoglycans at the extracellular matrix, role in spatiotemporal regulation of TGFbeta-related factors' biological activity
-
?
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Ca2+
-
dependent
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
A23187
-
if reticulocalbin-3 binds to proPACE4 transiently during its biosynthesis, this Ca2+-specific ionophore can block the maturation of proPACE4 to PACE4, accumulation of the proPaCE4-recticulocalbin-3 complex in the cells
Ac-(D)LLLLRVK-2,3-dehydroagmatine
-
Ac-(D)LLLLRVK-4-amidinobenzylamide
-
Ac-(D)LLLLRVKR-NH2
-
Ac-LLLLR-((2S)-amino-3S-guanidinobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 40
Ac-LLLLR-((2S,3R)-diaminobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 9
Ac-LLLLR-((2S,3S)-diaminobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 18
Ac-LLLLR-(2,3-diaminobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 12
Ac-LLLLR-(2,3-diaminopropionyl)-KR-NH2
Ki(furin)/Ki(PACE4): 51
Ac-LLLLR-(2-amino-3-guanidinopropionyl)-KR-NH2
Ki(furin)/Ki(PACE4): 19
Ac-LLLLR-(2-amino-4-guanidinobutyryl)-KR-NH2
Ki(furin)/Ki(PACE4): 10
Ac-LLLLR-Orn-KR-NH2
Ki(furin)/Ki(PACE4): 21
Ac-LLLLRAKR-NH2
Ki(furin)/Ki(PACE4): 7
Ac-LLLLRKKR-NH2
Ki(furin)/Ki(PACE4): 18
Ac-LLLLRRKR-NH2
Ki(furin)/Ki(PACE4): 12
Ac-LLLLRVK-2,3-dehydroagmatine
-
Ac-LLLLRVK-4-amidinobenzylamide
-
Ac-LLLLRVKR-NH2
Ac-[C8](D)LLLLRVK-4-amidinobenzylamide
-
Ac-[C8](D)LLLLRVKR-NH2
-
Ac-[C8]LLLLRVK-4-amidinobenzylamide
-
Ac-[C8]LLLLRVKR-NH2
-
Ac-[PEG2](D)LLLLRVK-4-amidinobenzylamide
-
Ac-[PEG2]LLLLRVKR-NH2
-
Ac-[PEG4]LLLLRVKR-NH2
-
Ac-[PEG8](D)LLLLRVK-2,3-dehydroagmatine
-
Ac-[PEG8](D)LLLLRVK-4-amidinobenzylamide
-
Ac-[PEG8](D)LLLLRVKR-NH2
-
Ac-[PEG8]LLLLRVK-2,3-dehydroagmatine
-
Ac-[PEG8]LLLLRVK-4-amidinobenzylamide
-
Ac-[PEG8]LLLLRVKR-NH2
-
alpha1-antitrypsin variant AVRR
-
50% inhibition above 0.002 mM
-
alpha1-antitrypsin variant PDX
-
50% inhibition above 0.00002 mM, forms a complex with the enzyme
-
alpha1-antitrypsin variant Portland
-
contains a minimal consensus sequence (Arg-X-X-Arg) for efficient cleavage by furin in its reactive site loop
-
alpha1-antitrypsin variant RRRRSA
-
rat alpha-antitrypsin showing substitution of Arg-Arg-Arg-Arg for Ala-Val-Pro-Met352 at P4-P1 and Ala for Leu354 at P2'
-
alpha1-antitrypsin variant RRRRSL
-
rat alpha-antitrypsin showing substitution of Arg-Arg-Arg-Arg for Ala-Val-Pro-Met352 at P4-P1
-
alpha1-antitrypsin variant RVRR
-
Ca2+
-
Ca2+ ionophore inhibits protein maturation
carboxyterminal sequence of PACE4
-
inhibits autocatalytic processing
-
decanoyl-Arg-Val-Lys-Arg-chloromethylketone
-
EDTA
-
85% inhibition at 20 mM
EGTA
-
inhibits at 0.5-2 mM
H2N-[C8](D)LLLLRVK-2,3-dehydroagmatine
-
H2N-[C8](D)LLLLRVKR-NH2
-
H2N-[C8]LLLLRVK-2,3-dehydroagmatine
-
H2N-[C8]LLLLRVK-4-amidinobenzylamide
-
H2N-[C8]LLLLRVKR-NH2
-
phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide
-
-
reticulocalbin-1
-
reduces efficiency of PACE4 secretion by 21%
-
[C8](D)LLLLRVK-2,3-dehydroagmatine
-
[C8](D)LLLLRVK-4-amidinobenzylamide
-
[C8](D)LLLLRVKR-NH2
-
[C8]LLLLRVK-2,3-dehydroagmatine
-
[C8]LLLLRVK-4-amidinobenzylamide
-
[C8]LLLLRVKR-NH2
-
additional information
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
heparin
-
below 1 mg/ml
reticulocalbin-3
-
efficiency of PACE4 secretion increases 2fold by coexpression with wild type reticulocalbin-3
-
additional information
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.0037
pGlu-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin
-
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.000013
Ac-(D)LLLLRVK-2,3-dehydroagmatine
pH 7.5, 37°C
0.0000049
Ac-(D)LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.000024
Ac-(D)LLLLRVKR-NH2
pH 7.5, 37°C
0.00011
Ac-LLLLR-((2S)-amino-3S-guanidinobutyryl)-KR-NH2
pH and temperature not specified in the publication
0.00051
Ac-LLLLR-((2S,3R)-diaminobutyryl)-KR-NH2
pH and temperature not specified in the publication
0.00027
Ac-LLLLR-((2S,3S)-diaminobutyryl)-KR-NH2
pH and temperature not specified in the publication
0.00066
Ac-LLLLR-(2,3-diaminobutyryl)-KR-NH2
pH and temperature not specified in the publication
0.00216
Ac-LLLLR-(2,3-diaminopropionyl)-KR-NH2
pH and temperature not specified in the publication
0.00055
Ac-LLLLR-(2-amino-3-guanidinopropionyl)-KR-NH2
pH and temperature not specified in the publication
0.000087
Ac-LLLLR-(2-amino-4-guanidinobutyryl)-KR-NH2
pH and temperature not specified in the publication
0.000105
Ac-LLLLR-Orn-KR-NH2
pH and temperature not specified in the publication
0.000195
Ac-LLLLRAKR-NH2
pH and temperature not specified in the publication
0.000083
Ac-LLLLRKKR-NH2
pH and temperature not specified in the publication
0.000088
Ac-LLLLRRKR-NH2
pH and temperature not specified in the publication
0.0000053
Ac-LLLLRVK-2,3-dehydroagmatine
pH 7.5, 37°C
0.0000031
Ac-LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.000022
Ac-LLLLRVKR-NH2
0.00001
Ac-[C8](D)LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.000055
Ac-[C8](D)LLLLRVKR-NH2
pH 7.5, 37°C
0.000003
Ac-[C8]LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.000023
Ac-[C8]LLLLRVKR-NH2
pH 7.5, 37°C
0.0000027
Ac-[PEG2](D)LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.000029
Ac-[PEG2]LLLLRVKR-NH2
pH 7.5, 37°C
0.000031
Ac-[PEG4]LLLLRVKR-NH2
pH 7.5, 37°C
0.000012
Ac-[PEG8](D)LLLLRVK-2,3-dehydroagmatine
pH 7.5, 37°C
0.0000029
Ac-[PEG8](D)LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.000045
Ac-[PEG8](D)LLLLRVKR-NH2
pH 7.5, 37°C
0.0000028
Ac-[PEG8]LLLLRVK-2,3-dehydroagmatine
pH 7.5, 37°C
0.0000007
Ac-[PEG8]LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.000019
Ac-[PEG8]LLLLRVKR-NH2
pH 7.5, 37°C
0.0000045
H2N-[C8](D)LLLLRVK-2,3-dehydroagmatine
pH 7.5, 37°C
0.00003
H2N-[C8](D)LLLLRVKR-NH2
pH 7.5, 37°C
0.0000034
H2N-[C8]LLLLRVK-2,3-dehydroagmatine
pH 7.5, 37°C
0.000001
H2N-[C8]LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.000045
H2N-[C8]LLLLRVKR-NH2
pH 7.5, 37°C
0.000056
[C8](D)LLLLRVK-2,3-dehydroagmatine
pH 7.5, 37°C
0.000024
[C8](D)LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.0001
[C8](D)LLLLRVKR-NH2
pH 7.5, 37°C
0.000045
[C8]LLLLRVK-2,3-dehydroagmatine
pH 7.5, 37°C
0.000016
[C8]LLLLRVK-4-amidinobenzylamide
pH 7.5, 37°C
0.000085
[C8]LLLLRVKR-NH2
pH 7.5, 37°C
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.04 - 0.21
Ac-(D)LLLLRVK-2,3-dehydroagmatine
0.025 - 0.04
Ac-(D)LLLLRVK-4-amidinobenzylamide
0.07 - 0.15
Ac-(D)LLLLRVKR-NH2
0.07 - 0.09
Ac-LLLLRVK-2,3-dehydroagmatine
0.025 - 0.04
Ac-LLLLRVK-4-amidinobenzylamide
0.1 - 0.18
Ac-LLLLRVKR-NH2
0.16
Ac-[C8](D)LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.04
Ac-[C8]LLLLRVK-4-amidinobenzylamide
0.08
Ac-[C8]LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.07
Ac-[PEG8](D)LLLLRVK-2,3-dehydroagmatine
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.11 - 0.15
Ac-[PEG8](D)LLLLRVKR-NH2
0.06 - 0.09
H2N-[C8](D)LLLLRVK-2,3-dehydroagmatine
0.09
H2N-[C8](D)LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.04 - 0.13
H2N-[C8]LLLLRVK-2,3-dehydroagmatine
0.046 - 0.047
H2N-[C8]LLLLRVK-4-amidinobenzylamide
0.015
H2N-[C8]LLLLRVKR-NH2
Homo sapiens
cell survival assay in DU145 cells, pH 7.5, 37°C
0.013 - 0.03
[C8]LLLLRVK-2,3-dehydroagmatine
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
additional information
preference of the enzyme for cleaving substrates at neutral pH
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
TEMPERATURE RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
22 - 30
-
markedly decreased enzyme activity
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
-
PACE4-C, PACE4-CS and PACE4-C
Manually annotated by BRENDA team
lower levels
Manually annotated by BRENDA team
lower levels
Manually annotated by BRENDA team
-
PACE4-C and PACE4-C
Manually annotated by BRENDA team
enzyme expression in non-small cell lung cancer cells is significantly higher than in normal lung cell and tissues
Manually annotated by BRENDA team
-
PACE4 is limited to the glia and the retina of the optic nerve head
Manually annotated by BRENDA team
the enzyme regulates apoptosis in human pancreatic cancer PANC-1 cells via the mitochondrial signaling pathway
Manually annotated by BRENDA team
-
PACE4 is limited to the glia and the retina of the optic nerve head
Manually annotated by BRENDA team
lower levels
Manually annotated by BRENDA team
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
the enzyme is constitutively secreted into the extracellular media and localizes at the cell surface and in the extracellular matrix
-
Manually annotated by BRENDA team
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
malfunction
when the PACE4 gene is silenced by small interfering RNA the knockdown of human breast cancer MDA-MB-231 cells shows significantly reduced proliferation, migration and invasion rates
metabolism
insulin receptor requires the proteolytic cleavage of its proform by intra-Golgi furin-like activity. In mammalian cells, insulin receptor is expressed as two isoforms B and A that are responsible for insulin action, but only isozyme A transmits the growth-promoting and mitogenic effects of insulin-like growth factor 2. The two insulin receptor isoforms are similarly cleaved by furin, but when this furin-dependent maturation is inefficient, insulin receptor proforms move to the cell surface where the proprotein convertase PACE4 selectively supports insulin receptor B maturation
physiological function
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
PCSK6_HUMAN
969
0
106420
Swiss-Prot
-
PCSK4_HUMAN
755
0
82795
Swiss-Prot
-
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
103000
105000
SDS-PAGE, mature protein
110000
112000
SDS-PAGE, precursor protein
120000
-
SDS-PAGE
150000
-
PACE4-A, SDS-PAGE
230000
-
SDS-PAGE, precursor protein, dimeric form
77000
-
PACE4-CS, SDS-PAGE
95000
-
SDS-PAGE
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
dimer
-
precursor protein can exist as a dimer as well as a monomer, sedimentation velocity experiments and chemical cross-linking analysis
monomer
-
mature protein and precursor protein, sedimentation velocity experiments and chemical cross-linking analysis
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
proteolytic modification
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
D205N
-
mutant enzyme does not undergo endoproteolytic cleavage
K144R
-
no difference to wild-type enzyme
R149Q
-
mutant enzyme does not undergo endoproteolytic cleavage
S420A
-
mutant enzyme does not undergo endoproteolytic cleavage
additional information
-
deletion of 25 amino acids at the C-terminus results in accelerated maturation of the protein
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
expressed in IMR90 fibroblasts and HT1080 fibrosarcoma cells
-
expressed in MDA-MB-231 cells
-
expressed in mutant CHO-derived PgsD-677 cells and Mus musculus liver
-
expression in furin-deficient cells
-
full length PACE4-A, C-terminally truncated PACE4-C which lacks 11 amino acids a t the end of its chaperone-like P-domain, C-terminally shortened version of PACE4-C and PACE4-CS
-
isoform PACE4A-I
-
isoform PACE4E-I and truncated mutant, expressed in COS-1 cells
isoform PACE4E-II expressed in COS-1 cells
recombinant enzyme expression in LoVo, HeLa, and HEK293 cells
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
diagnostics
expression of the enzyme correlates with prognosis in non-small cell lung cancer patients. Overall survival is significantly prolonged in PACE4 negative group when compared with PACE4 positive group (5-year survival rates, 23.1% vs. 54.5%, log-rank test), as is disease-free survival (5-year survival rates, 23.4% vs. 55.4%). Positive expression of PACE4 is an independent factor for non-small cell lung cancer patients and it might serve as a potential prognostic biomarker for patients with non-small cell lung cancer
medicine
additional information
-
selective and transient association of reticulocalbin-3 with the precursor of PACE4 plays an important role in the biosynthesis of PACE4
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Taniguchi, T.; Kuroda, R.; Sakurai, K.; Nagahama, M.; Wada, I.; Tsuji, A.; Matsuda, Y.
A critical role for the carboxy terminal region of the proprotein convertase, PACE4A, in the regulation of its autocatalytic activation coupled with secretion
Biochem. Biophys. Res. Commun.
290
878-884
2002
Homo sapiens
Manually annotated by BRENDA team
Sucic, J.F.; Moehring, J.M.; Inocencio, N.M.; Luchini, J.W.; Moehring, T.J.
Endoprotease PACE4 is Ca2+-dependent and temperature-sensitive and can partly rescue the phenotype of a furin-deficient cell strain
Biochem. J.
339
639-647
1999
Homo sapiens
Manually annotated by BRENDA team
Rehemtulla, A.; Barr, P.J.; Rhodes, C.J.; Kaufman, R.J.
PACE4 is a member of the mammalian propeptidase family that has overlapping but not identical substrate specificity to PACE
Biochemistry
32
11586-11590
1993
Homo sapiens
Manually annotated by BRENDA team
Tsuji, A.; Sakurai, K.; Kiyokage, E.; Yamazaki, T.; Koide, S.; Toida, K.; Ishimura, K.; Matsuda, Y.
Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix
Biochim. Biophys. Acta
1645
95-104
2003
Homo sapiens
Manually annotated by BRENDA team
Pinnix, I.; Council, J.E.; Roseberry, B.; Onstead, L.; Mallender, W.; Sucic, J.; Sambamurti, K.
Convertases other than furin cleave beta-secretase to its mature form
FASEB J.
15
1810-1812
2001
Homo sapiens
Manually annotated by BRENDA team
Creemers, J.W.; Groot Kormelink, P.J.; Roebroek, A.J.; Nakayama, K.; Van de Ven, W.J.
Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4
FEBS Lett.
336
65-69
1993
Homo sapiens
Manually annotated by BRENDA team
Zhong, M.; Benjannet, S.; Lazure, C.; Munzer, S.; Seidah, N.G.
Functional analysis of human PACE4-A and PACE4-C isoforms: identification of a new PACE4-CS isoform
FEBS Lett.
396
31-36
1996
Homo sapiens
Manually annotated by BRENDA team
Nagahama, M.; Taniguchi, T.; Hashimoto, E.; Imamaki, A.; Mori, K.; Tsuji, A.; Matsuda, Y.
Biosynthetic processing and quaternary interactions of proprotein convertase SPC4 (PACE4)
FEBS Lett.
434
155-159
1998
Homo sapiens
Manually annotated by BRENDA team
Mori, K.; Kii, S.; Tsuji, A.; Nagahama, M.; Imamaki, A.; Hayashi, K.; Akamatsu, T.; Nagamune, H.; Matsuda, Y.
A novel human PACE4 isoform, PACE4E is an active processing protease containing a hydrophobic cluster at the carboxy terminus
J. Biochem.
121
941-948
1997
Homo sapiens (P29122), Homo sapiens
Manually annotated by BRENDA team
Mori, K.; Imamaki, A.; Nagata, K.; Yonetomi, Y.; Kiyokage-Yoshimoto, R.; Martin, T.J.; Gillespie, M.T.; Nagahama, M.; Tsuji, A.; Matsuda, Y.
Subtilisin-like proprotein convertases, PACE4 and PC8, as well as furin, are endogenous proalbumin convertases in HepG2 cells
J. Biochem.
125
627-633
1999
Homo sapiens
Manually annotated by BRENDA team
Tsuji, A.; Ikoma, T.; Hashimoto, E.; Matsuda, Y.
Development of selectivity of alpha1-antitrypsin variant by mutagenesis in its reactive site loop against proprotein convertase. A crucial role of the P4 arginine in PACE4 inhibition
Protein Eng.
15
123-130
2002
Homo sapiens
Manually annotated by BRENDA team
Tsuji, A.; Kikuchi, Y.; Sato, Y.; Koide, S.; Yuasa, K.; Nagahama, M.; Matsuda, Y.
A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4
Biochem. J.
396
51-59
2006
Homo sapiens
Manually annotated by BRENDA team
Mains, R.E.
Proprotein convertase PACE4
Handbook of Proteolytic Enzymes (Barrett, A. J. , Rawlings, N. D. , Woessner, J. F. , Eds. ) Academic Press
2
1871-1874
2004
Aplysia sp., Mus musculus, Homo sapiens (P29122), Rattus norvegicus (Q63415)
-
Manually annotated by BRENDA team
Lapierre, M.; Siegfried, G.; Scamuffa, N.; Bontemps, Y.; Calvo, F.; Seidah, N.G.; Khatib, A.M.
Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells malignant phenotypes: role of tissue inhibitors of metalloproteinase-1
Cancer Res.
67
9030-9034
2007
Homo sapiens
Manually annotated by BRENDA team
Page, R.E.; Klein-Szanto, A.J.; Litwin, S.; Nicolas, E.; Al-Jumaily, R.; Alexander, P.; Godwin, A.K.; Ross, E.A.; Schilder, R.J.; Bassi, D.E.
Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer
Cell. Oncol.
29
289-299
2007
Homo sapiens
Manually annotated by BRENDA team
Yuasa, K.; Suzue, K.; Nagahama, M.; Matsuda, Y.; Tsuji, A.
Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progression
Gene
402
103-110
2007
Homo sapiens
Manually annotated by BRENDA team
Seidah, N.G.; Mayer, G.; Zaid, A.; Rousselet, E.; Nassoury, N.; Poirier, S.; Essalmani, R.; Prat, A.
The activation and physiological functions of the proprotein convertases
Int. J. Biochem. Cell Biol.
40
1111-1125
2008
Homo sapiens
Manually annotated by BRENDA team
Tsuji, A.; Kanie, H.; Makise, H.; Yuasa, K.; Nagahama, M.; Matsuda, Y.
Engineering of alpha 1-antitrypsin variants selective for subtilisin-like proprotein convertases PACE4 and PC6: importance of the P2 residue in stable complex formation of the serpin with proprotein convertase
Protein Eng. Des. Sel.
20
163-170
2007
Homo sapiens
Manually annotated by BRENDA team
Freyer, C.; Kilpatrick, L.M.; Salamonsen, L.A.; Nie, G.
Pro-protein convertases (PCs) other than PC6 are not tightly regulated for implantation in the human endometrium
Reproduction
133
1189-1197
2007
Homo sapiens (P29122), Homo sapiens
Manually annotated by BRENDA team
Remacle, A.G.; Shiryaev, S.A.; Oh, E.S.; Cieplak, P.; Srinivasan, A.; Wei, G.; Liddington, R.C.; Ratnikov, B.I.; Parent, A.; Desjardins, R.; Day, R.; Smith, J.W.; Lebl, M.; Strongin, A.Y.
Substrate cleavage analysis of furin and related proprotein convertases. A comparative study
J. Biol. Chem.
283
20897-20906
2008
Homo sapiens (P29122), Homo sapiens
Manually annotated by BRENDA team
Xiao, Y.; Chen, G.; Richard, J.; Rougeau, N.; Li, H.; Seidah, N.G.; Cohen, E.A.
Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases
Virology
372
384-397
2008
Homo sapiens (Q6UW60), Homo sapiens
Manually annotated by BRENDA team
Fuller, J.A.; Brun-Zinkernagel, A.M.; Clark, A.F.; Wordinger, R.J.
Subtilisin-like proprotein convertase expression, localization, and activation in the human retina and optic nerve head
Invest. Ophthalmol. Vis. Sci.
50
5759-5768
2009
Homo sapiens
Manually annotated by BRENDA team
Kara, I.; Poggi, M.; Bonardo, B.; Govers, R.; Landrier, J.F.; Tian, S.; Leibiger, I.; Day, R.; Creemers, J.W.; Peiretti, F.
The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2)
J. Biol. Chem.
290
2812-2821
2015
Homo sapiens (P29122)
Manually annotated by BRENDA team
Kwiatkowska, A.; Couture, F.; Levesque, C.; Ly, K.; Beauchemin, S.; Desjardins, R.; Neugebauer, W.; Dory, Y.L.; Day, R.
Novel insights into structure-activity relationships of N-terminally modified PACE4 inhibitors
ChemMedChem
11
289-301
2016
Homo sapiens (P29122)
Manually annotated by BRENDA team
Dianati, V.; Shamloo, A.; Kwiatkowska, A.; Desjardins, R.; Soldera, A.; Day, R.; Dory, Y.L.
Rational design of a highly potent and selective peptide inhibitor of PACE4 by salt bridge interaction with D160 at position P3
ChemMedChem
12
1169-1172
2017
Homo sapiens (P29122)
Manually annotated by BRENDA team
Yao, Z.; Sun, B.; Hong, Q.; Yan, J.; Mu, D.; Li, J.; Sheng, H.; Guo, H.
PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathways
Drug Des. Devel. Ther.
9
5911-5923
2015
Homo sapiens (P29122), Homo sapiens
Manually annotated by BRENDA team
Lin, Y.E.; Wu, Q.N.; Lin, X.D.; Li, G.Q.; Zhang, Y.J.
Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients
J. Thorac. Dis.
7
850-860
2015
Homo sapiens (P29122), Homo sapiens
Manually annotated by BRENDA team
Wang, F.; Wang, L.; Pan, J.
PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells
Mol. Med. Rep.
11
698-704
2015
Homo sapiens (P29122), Homo sapiens
Manually annotated by BRENDA team
Tian, X.F.; Huang, G.M.; Zang, H.L.; Cao, H.
PACE4 regulates apoptosis in human pancreatic cancer Panc-1 cells via the mitochondrial signaling pathway
Mol. Med. Rep.
14
5205-5210
2016
Homo sapiens (P29122), Homo sapiens
Manually annotated by BRENDA team